• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与老年人群接受肾脏替代治疗的发生率差异相关的因素:来自 ERA-EDTA 登记处的数据。

Factors associating with differences in the incidence of renal replacement therapy among elderly: data from the ERA-EDTA Registry.

机构信息

Finnish Registry for Kidney Diseases, Helsinki, Finland.

Abdominal Center Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

出版信息

Nephrol Dial Transplant. 2018 Aug 1;33(8):1428-1435. doi: 10.1093/ndt/gfy056.

DOI:
10.1093/ndt/gfy056
PMID:29684185
Abstract

BACKGROUND

The incidence of renal replacement therapy (RRT) in the general population ≥75 years of age varies considerably between countries and regions in Europe. Our aim was to study characteristics and survival of elderly RRT patients and to find explanations for differences in RRT incidence.

METHODS

Patients ≥75 years of age at the onset of RRT in 2010-2013 from 29 national or regional registries providing data to the European Renal Association-European Dialysis and Transplant Association Registry were included. Chi-square and Mann-Whitney U tests were used to assess variation in patient characteristics and linear regression was used to study the association between RRT incidence and various factors. Kaplan-Meier curves and Cox regression were employed for survival analyses.

RESULTS

The mean annual incidence of RRT in the age group ≥75 years of age ranged from 157 to 924 per million age-related population. The median age at the start of RRT was higher and comorbidities were less common in areas with higher RRT incidence, but overall the association between patient characteristics and RRT incidence was weak. The unadjusted survival was lower in high-incidence areas due to an older age at onset of RRT, but the adjusted survival was similar [relative risk 1.00 (95% confidence interval, 0.97-1.03)] in patients from low- and high-incidence areas.

CONCLUSIONS

Variation in the incidence of RRT among the elderly across European countries and regions is remarkable and could not be explained by the available data. However, the survival of patients in low- and high-incidence areas was remarkably similar.

摘要

背景

在欧洲,≥75 岁的普通人群中接受肾脏替代治疗(RRT)的发病率在各国和各地区之间存在很大差异。我们的目的是研究老年 RRT 患者的特征和生存率,并寻找 RRT 发病率差异的解释。

方法

纳入了 2010-2013 年来自 29 个国家或地区的 RRT 登记处的数据,这些登记处提供的数据均被纳入欧洲肾脏协会-欧洲透析与移植协会登记处。采用卡方检验和曼-惠特尼 U 检验来评估患者特征的差异,采用线性回归来研究 RRT 发病率与各种因素之间的关系。采用 Kaplan-Meier 曲线和 Cox 回归进行生存分析。

结果

≥75 岁年龄组的 RRT 年平均发病率范围为每百万与年龄相关人口 157 至 924 例。RRT 起始时的中位年龄较高,且发病率较高的地区合并症较少,但患者特征与 RRT 发病率之间的总体关联较弱。由于 RRT 起始年龄较大,高发病率地区的未调整生存率较低,但低和高发病率地区的调整生存率相似[相对风险 1.00(95%置信区间,0.97-1.03)]。

结论

欧洲各国和地区之间老年人群 RRT 发病率的差异显著,且无法用现有数据解释。然而,低和高发病率地区患者的生存率非常相似。

相似文献

1
Factors associating with differences in the incidence of renal replacement therapy among elderly: data from the ERA-EDTA Registry.与老年人群接受肾脏替代治疗的发生率差异相关的因素:来自 ERA-EDTA 登记处的数据。
Nephrol Dial Transplant. 2018 Aug 1;33(8):1428-1435. doi: 10.1093/ndt/gfy056.
2
Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry.欧洲接受肾脏替代治疗的系统性硬化症(硬皮病)患者的特征和结局:来自 ERA-EDTA 登记处的结果。
Am J Kidney Dis. 2019 Feb;73(2):184-193. doi: 10.1053/j.ajkd.2018.05.016. Epub 2018 Aug 16.
3
Lifetime risk of renal replacement therapy in Europe: a population-based study using data from the ERA-EDTA Registry.欧洲接受肾脏替代治疗的终生风险:基于人群的研究,使用 ERA-EDTA 登记处的数据。
Nephrol Dial Transplant. 2017 Feb 1;32(2):348-355. doi: 10.1093/ndt/gfw392.
4
The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry.肾脏替代治疗的变化趋势和结果:来自 ERA-EDTA 登记处的数据。
Nephrol Dial Transplant. 2016 May;31(5):831-41. doi: 10.1093/ndt/gfv327. Epub 2015 Sep 11.
5
An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006.欧洲肾脏替代治疗的最新进展:1997 年至 2006 年 ERA-EDTA 登记数据。
Nephrol Dial Transplant. 2009 Dec;24(12):3557-66. doi: 10.1093/ndt/gfp519. Epub 2009 Oct 9.
6
Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study.多发性骨髓瘤或轻链沉积病导致终末期肾病开始肾脏替代治疗患者的发病率和结局:ERA-EDTA 登记研究。
Nephrol Dial Transplant. 2010 Apr;25(4):1200-6. doi: 10.1093/ndt/gfp679. Epub 2009 Dec 27.
7
Differences in renal registries between the Balkans and Western Europe.巴尔干半岛与西欧之间肾脏登记情况的差异。
Prilozi. 2006 Dec;27(2):37-47.
8
Disparities in treatment rates of paediatric end-stage renal disease across Europe: insights from the ESPN/ERA-EDTA registry.欧洲儿童终末期肾病治疗率的差异:来自ESPN/ERA-EDTA注册研究的见解
Nephrol Dial Transplant. 2015 Aug;30(8):1377-85. doi: 10.1093/ndt/gfv064. Epub 2015 Apr 2.
9
The 2006 ERA-EDTA Registry annual report: a précis.2006年欧洲肾脏最佳实践(ERA)-欧洲透析与移植协会(EDTA)登记处年度报告:概述
J Nephrol. 2009 Jan-Feb;22(1):1-12.
10
Demographics of paediatric renal replacement therapy in Europe: a report of the ESPN/ERA-EDTA registry.欧洲儿童肾脏替代治疗的人口统计学:ESPN/ERA-EDTA登记处报告
Pediatr Nephrol. 2014 Dec;29(12):2403-10. doi: 10.1007/s00467-014-2884-6. Epub 2014 Jul 21.

引用本文的文献

1
Maintaining kidney health in aging societies: a JSN and ERA call to action.在老龄化社会中维护肾脏健康:日本肾脏病学会和欧洲肾脏协会的行动呼吁。
Nephrol Dial Transplant. 2025 Apr 10. doi: 10.1093/ndt/gfaf068.
2
Variability in the incidence of renal replacement therapy over time in Western industrialized countries: A retrospective registry analysis.西方工业化国家肾替代治疗发病率随时间的变化:一项回顾性登记分析。
PLoS One. 2020 Jun 25;15(6):e0235004. doi: 10.1371/journal.pone.0235004. eCollection 2020.
3
Nephrology and Public Policy Committee propositions to stimulate research collaboration in adults and children in Europe.
肾脏病学和公共政策委员会提议在欧洲促进成人和儿童的研究合作。
Nephrol Dial Transplant. 2019 Sep 1;34(9):1469-1480. doi: 10.1093/ndt/gfz089.